ArticleAntimicrobial agents and chemotherapy2024

Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19.

Lindsay E Clegg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.